Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Letter to the Editor

Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”

Yun-Fan Liaw

Clin Mol Hepatol. 2024;30(2):269-271. Published online January 31, 2024

DOI: https://doi.org/10.3350/cmh.2024.0064

View: 1874 Download: 39 Web of Science: 1 Crossref: 1

Editorial

Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen

Chen-Te Huang, Tai-Chung Tseng

Clin Mol Hepatol. 2024;30(2):154-156. Published online February 22, 2024

DOI: https://doi.org/10.3350/cmh.2024.0120

View: 1926 Download: 58 Crossref: 1

Review

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 13398 Download: 547 Web of Science: 49 Crossref: 48

Original Article

Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients

Jae Young Jang, Soung Won Jeong, Sung Ran Cheon, Sae Hwan Lee, Sang Gyune Kim, Young Koog Cheon, Young Seok Kim, Young Deok Cho, Hong Soo Kim, So Young Jin, Yun Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2011;17(3):206-212. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.206

View: 8756 Download: 65 Crossref: 12

3

Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment

Jae Kwon Jung, M.D., Chang Hyeong Lee, M.D., Eun Young Kim, M.D., Jin Tae Jung, M.D., Joon Hyuck Choi, M.D., Ji Min Han, M.D., Myoung In Jin, M.D., Ju Yeon Cho, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.

Clin Mol Hepatol. 2007;13(4):513-520. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.513

View: 3799 Download: 28

7

The Korean Journal of Serum Hepatitis B Virus DHA Level and Hepatocellulor Carcinoma

Seong Gyu Hwang

Clin Mol Hepatol. 2006;12(4):583-586. Published online January 1, 1970

View: 2525 Download: 15

3

Serum ALT and HBV DNA Levels in Patients with HBeAg-Negative Chronic Hepatitis B

Kyung Hwan Kim, M.D., Il Hwan Na, M.D., Jae Moon Cha, M.D., Yong Ki Cho, M.D., Se Young Park, M.D., Hyoung Pil Kim, M.D., Chul Soo Song, M.D., Jeong Heo, M.D. and Mong Cho, M.D.

Clin Mol Hepatol. 2003;9(4):284-292. Published online January 1, 2000

View: 3132 Download: 29

The Clinical Significance of Quantitation of HBV DNA in Serum : Comparison of the Branched-DNA Assay with the Second-Generation Digene Hybrid Capture Assay and Long-term Observation

Eun Jung Jun, M.D., Joon-Yeol Han, M.D., Hwang Choi, M.D., U Im Chang, M.D., Tae Kyu Lee, M.D., Young Hwan Kim, M.D., Jin Il Kim, M.D., Soo Heon Park, M.D., Jae Kwang Kim, M.D., Kyu Won Chung, M.D. and Hee Sik Sun, M.D.

Clin Mol Hepatol. 2002;8(2):157-166. Published online January 1, 2000

View: 2313 Download: 18

HBV DNA Levels, Aminotransferase and Histological Activity in Young Male Patients with HBeAg Positive Chronic Hepatitis B

Seung Chul Cho,Soong Hwan Lee,Joon Jae Shinn,Sung Hee Han,Byung Joo Roh,Joo Hyun Sohn,Dong Hoo Lee,Choon Suhk Kee

Clin Mol Hepatol. 2002;8(1):44-51. Published online January 1, 2000

View: 2774 Download: 28

A Prospective Study of Therapeutic Effect of 6 Months Trial with Lamivudine in Patients with Chronic Viral Hepatitis B

Chang Woo Gham,Soong Hwan Lee,Seung Woo Nam,Seung Woo Nam,Byung Joo Roh,Dong Hoo Lee

Clin Mol Hepatol. 1999;5(4):282-290. Published online January 1, 2000

View: 2318 Download: 11

Emergence of YMDD Motif Mutant Hepatitis B Virus during Short-term Lamivudine Therapy

Yong Han Paik,Kwang Hyub Han,Hyo Young Chung,Chae Yoon Chun,Young Myoung Moon

Clin Mol Hepatol. 1999;5(3):173-183. Published online January 1, 2000

View: 4296 Download: 15

Persistent Negative Anti-HBc in Chronic Hepatitis B Virus Carrier -Clinical Review, HBcAg and Nucleotide Sequence of It`s Epitope in HLA A2 Heterozygotes-

Jae Heung Kim,Haak Cheoul Kim

Clin Mol Hepatol. 1999;5(2):105-115. Published online January 1, 2000

View: 2374 Download: 15

The Effect of Long-term Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus

Kwang Hyub Han, M.D., Jin Suk Kim, M.D., Hyo Young Chung Sang Hoon Ahn, M.D., Yong Han Paik, M.D., Kwan Sik Lee, M.D., Chae Yoon Chon, M.D. and Young Myoung Moon, M.D.

Clin Mol Hepatol. 1999;5(2):97-104. Published online January 1, 2000

View: 2471 Download: 14

1 |

Viewed By 5240	MAFLD: How is it different from NAFLD?
Viewed By 4997	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4905	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4672	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4650	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 162	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 136	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 120	MAFLD: How is it different from NAFLD?
Cited By 98	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search